WUHAN, April 19 (Xinhua) -- The newly approved Chinese recombinant protein subunit vaccine against COVID-19 has been available in Wuhan, the capital of central China's Hubei Province.
The recombinant vaccine (CHO Cells) for people aged 18 and above requires three shots over six months. The minimum interval is four weeks between two adjacent doses.
It is another COVID-19 vaccine that Wuhan residents can be vaccinated with after inactivated vaccines.
The vaccination process for the recombinant COVID-19 vaccines is the same as that of inactivated vaccine. After people are vaccinated, they should be monitored on-site for at least 30 minutes. Medical personnel will inform vaccine-takers that the recombinant vaccine requires three shots over six months, while the two-shot inactivated vaccine needs an interval of 28 to 56 days between the two doses.
"People will achieve immunity by getting either of the vaccines," said Peng Rong, a local medical worker at a vaccination site.
The recombinant vaccine was jointly developed by the Institute of Microbiology under the Chinese Academy of Sciences and Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. It can be transported and stored at a temperature ranging from 2 to 8 degrees Celsius.
China issued emergency use authorization of the vaccine on March 10.